What should you know about peripheral cholangiocarcinoma?

Cholangiocarcinoma is a cancer arising from cells lining the bile ducts. Peripheral, also called intrahepatic, indicates that the tumour is in bile ducts located within the liver rather than at the main duct junction or outside the liver. A tumour may affect nearby liver tissue and blood vessels, and symptoms vary with its size and position.

Possible features include abdominal discomfort, tiredness, poor appetite, weight loss, fever or yellowing of the skin and eyes. These symptoms have many causes and do not establish bile duct cancer. Blood tests, ultrasound or other scans, and sometimes a biopsy help the team assess the liver and clarify the diagnosis.

A specialist team reviews imaging to determine whether the tumour can be removed and how much liver is involved. When surgery is suitable, the operation may remove the tumour with a planned section of liver and nearby tissue. Tumour removal surgery can require careful assessment of liver function and recovery needs.

If surgery is not suitable or does not address all disease, chemotherapy may be discussed. Targeted therapy may be an option when tumour testing identifies a change for which an appropriate medicine exists. Ask whether molecular testing is relevant and how treatment goals, side effects and monitoring will be handled.

Arrange medical review for persistent upper abdominal discomfort, unexplained jaundice, dark urine, pale stools, ongoing itching, fever or unintentional weight loss. Seek urgent care for severe abdominal pain, confusion, repeated vomiting, high fever with shaking chills, or yellowing that develops quickly.

Where is the tumour located and has it spread? Is surgery possible? Do I need a biopsy or molecular testing? Which treatment is recommended first, and what side effects should I report urgently? How will liver function and response be monitored?